Current state and potential applications of neonatal Fc receptor (FcRn) inhibitors in hematologic conditions

Overview of attention for article published in American Journal of Hematology, September 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 12 X users

Readers on

mendeley: 27 Mendeley

So far, Altmetric has seen 16 X posts from 12 X users, with an upper bound of 14,736 followers.

@JackHadfield14 @NationalAnthemX I'd like to see some trials of FcRn inhibitors in LC cases with autoimmune+ profiles. IgG specific, leaves other isotypes alone, and more practical for long-term suppression than, e.g., immunoadsorption. https://t.co/I…

RT @AjHematology: Current clinical trial data suggest neonatal Fc receptor (FcRn) inhibitors lower circulating IgG levels without serious a…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 12 additional X posts.